Mathematical Modeling of Herpes Simplex Virus Distribution in Solid Tumors: Implications for Cancer Gene Therapy

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Clinical Cancer Research

• Publication date

  2009-04-01

• Fields of study

  Biology, Medicine, Mathematics

• Identifiers
  DOI 10.1158/1078-0432.CCR-08-2082PMID 19318482PMCID PMC2872130
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer cell death enhances the penetration and efficacy of oncolytic herpes simplex virus in tumors.

  2008cited by this paper
• Quantitative spatiotemporal analysis of antibody fragment diffusion and endocytic consumption in tumor spheroids.

  2008cited by this paper
• Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress

  2007cited by this paper
• Matrix metalloproteinases-1 and -8 improve the distribution and efficacy of an oncolytic virus.

  2007cited by this paper
• Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector.

  2006cited by this paper
• Widespread intratumoral virus distribution with fractionated injection enables local control of large human rhabdomyosarcoma xenografts by oncolytic herpes simplex viruses

  2005cited by this paper
• The competitive dynamics between tumor cells, a replication-competent virus and an immune response

  2005cited by this paper
• Replicative oncolytic herpes simplex viruses in combination cancer therapies.

  2004cited by this paper
• Systemic dissemination of viral vectors during intratumoral injection.

  2003cited by this paper
• Intratumoral Spread of Wild-Type Adenovirus Is Limited After Local Injection of Human Xenograft Tumors: Virus Persists and Spreads Systemically at Late Time Points

  2003cited by this paper
• Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation

  2003cited by this paper
• Validation and analysis of a mathematical model of a replication-competent oncolytic virus for cancer treatment: implications for virus design and delivery.

  2003cited by this paper
• Direct comparison of binding equilibrium, thermodynamic, and rate constants determined by surface‐ and solution‐based biophysical methods

  2002cited by this paper
• Prerequisites for effective adenovirus mediated gene therapy of colorectal liver metastases in the rat using an intracellular neutralizing antibody fragment to p21-Ras

  2002cited by this paper
• Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.

  2002cited by this paper
• A thermodynamic characterization of the binding of thrombin inhibitors to human thrombin, combining biosensor technology, stopped-flow spectrophotometry, and microcalorimetry.

  2002cited by this paper
• Diffusion and convection in collagen gels: implications for transport in the tumor interstitium.

  2002cited by this paper
• Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer.

  2001cited by this paper
• Viruses as antitumor weapons: defining conditions for tumor remission.

  2001cited by this paper
• Delivery of molecular and cellular medicine to solid tumors.

  2001cited by this paper
• Role of tumor–host interactions in interstitial diffusion of macromolecules: Cranial vs. subcutaneous tumors

  2001cited by this paper
• Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry.

  2001cited by this paper
• Role of extracellular matrix assembly in interstitial transport in solid tumors.

  2000cited by this paper
• Available volume fraction of macromolecules in the extravascular space of a fibrosarcoma: implications for drug delivery.

  1999cited by this paper
• Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications.

  1999cited by this paper
• Examination of the Kinetics of Herpes Simplex Virus Glycoprotein D Binding to the Herpesvirus Entry Mediator, Using Surface Plasmon Resonance

  1998cited by this paper
• Thermodynamic analysis of protein interactions with biosensor technology

  1998cited by this paper
• Heparan Sulfate Proteoglycan Binding by Herpes Simplex Virus Type 1 Glycoproteins B and C, Which Differ in Their Contributions to Virus Attachment, Penetration, and Cell-to-Cell Spread

  1998cited by this paper
• Intratumoral infusion of fluid: estimation of hydraulic conductivity and implications for the delivery of therapeutic agents.

  1998cited by this paper
• The next frontier of molecular medicine: Delivery of therapeutics

  1998cited by this paper
• Microtubule-mediated Transport of Incoming Herpes Simplex Virus 1 Capsids to the Nucleus

  1997cited by this paper
• Identification and minimization of nonideal binding effects in BIAcore analysis: ferritin/anti-ferritin Fab' interaction as a model system.

  1997cited by this paper
• Delivery of Molecular and Cellular Medicine to Solid Tumors

  1997cited by this paper
• Specificity and affinity of binding of herpes simplex virus type 2 glycoprotein B to glycosaminoglycans

  1997cited by this paper
• ROTATION OF A SPHERE IN BRINKMAN FLUIDS

  1996cited by this paper
• Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B.

  1994cited by this paper
• Convection-enhanced delivery of macromolecules in the brain.

  1994cited by this paper
• Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells

  1994cited by this paper
• Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft.

  1994cited by this paper
• Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans

  1992cited by this paper
• Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity

  1991cited by this paper
• Transport of fluid and macromolecules in tumors. III. Role of binding and metabolism.

  1991cited by this paper
• Hindered transport in fibrous membranes and gels: Effect of solute size and fiber configuration

  1990cited by this paper
• Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection.

  1989cited by this paper
• Initial interaction of herpes simplex virus with cells is binding to heparan sulfate

  1989cited by this paper
• Hindered transport of spherical macromolecules in fibrous membranes and gels

  1989cited by this paper
• Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching.

  1989cited by this paper
• Linker-insertion nonsense and restriction-site deletion mutations of the gB glycoprotein gene of herpes simplex virus type 1

  1987cited by this paper
• Microvascular permeability of normal and neoplastic tissues.

  1986cited by this paper
• Accessibility of circulating immunoglobulin G to the extravascular compartment of solid rat tumors.

  1984cited by this paper
• The extracellular space in brain tumours. II. The sucrose space.

  1970cited by this paper
• The extracellular space in brain tumours. I. Morphological considerations.

  1970cited by this paper
• THE INTERSTITIAL WATER SPACE OF TUMORS.

  1965cited by this paper

• How do viruses get around? A review of mathematical modeling of in-host viral transmission.

  2025cites this paper
• Synergistic mechanotherapy and sonopermeation guided by mathematical modeling for solid tumor treatment

  2025cites this paper
• Pharmacokinetics, Biodistribution, Immunogenicity, and Model-Informed-Based PK/PD Model of a Next-Generation Advanced Novel Gene Therapy for Hemophilia.

  2025cites this paper
• Mathematical Model of Infection Propagation Mediated by Circulating Macrophages

  2025cites this paper
• From infection to remedy: Harnessing oncolytic viruses in cancer treatment.

  2025cites this paper
• Infection propagation in a tissue with resident macrophages.

  2025cites this paper
• Spatially structured models of viral dynamics: a scoping review

  2025cites this paper
• The role of viral dynamics and infectivity in models of oncolytic virotherapy for tumours with different motility

  2025cites this paper
• Oscillations in a Spatial Oncolytic Virus Model

  2024cites this paper
• A phenotype-structured mathematical model for the influence of hypoxia on oncolytic virotherapy.

  2024cites this paper
• Electromechanical convective drug delivery devices for overcoming diffusion barriers.

  2024cites this paper
• Assessment of Clinical Response to V937 Oncolytic Virus After Intravenous or Intratumoral Administration Using Physiologically‐Based Modeling

  2023cites this paper
• Mathematical modeling of intratumoral immunotherapy yields strategies to improve the treatment outcomes

  2023cites this paper
• Prospective approaches to gene therapy computational modeling – spotlight on viral gene therapy

  2023cites this paper
• Agent-Based and Continuum Models for Spatial Dynamics of Infection by Oncolytic Viruses

  2023cites this paper
• Time delay induces a back to back Hopf bifurcation on oncolytic virotherapy.

  2023cites this paper
• Continuum and discrete models of oncolytic virotherapy in different tumour microenvironments

  2023cites this paper
• Modelling the spatial dynamics of oncolytic virotherapy in the presence of virus-resistant tumour cells

  2022cites this paper
• Agent-based computational modeling of glioblastoma predicts that stromal density is central to oncolytic virus efficacy

  2022cites this paper
• Inducing Biomechanical Heterogeneity in Brain Tumor Modeling by MR Elastography: Effects on Tumor Growth, Vascular Density and Delivery of Therapeutics

  2022cites this paper
• Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy?

  2022cites this paper
• Improving immunovirotherapies: the intersection of mathematical modelling and experiments

  2022cites this paper
• Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapy

  2022cites this paper
• To Explore the Stem Cells Homing to GBM: The Rise to the Occasion

  2022cites this paper
• The End-to-End Molecular Communication Model of Extracellular Vesicle-Based Drug Delivery

  2022cites this paper
• Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2

  2022cites this paper
• Quantitative imaging and dynamics of tumor therapy with viruses

  2021cites this paper
• Current progress and limitations of AAV mediated delivery of protein therapeutic genes and the importance of developing quantitative pharmacokinetic/pharmacodynamic (PK/PD) models.

  2021cites this paper
• Solvability of Solid Tumor Invasion Model

  2021cites this paper
• Opportunities and challenges for applying model‐informed drug development approaches to gene therapies

  2021cites this paper
• Prospect for application of mathematical models in combination cancer treatments

  2021cites this paper
• Solvability of Solid Tumor Invasion Model

  2021cites this paper
• A simple two-strain HSV epidemic model with palliative treatment

  2021cites this paper
• Oncolytic virus therapy in cancer: A current review

  2021cites this paper
• Mechanistic Modeling of a Novel Oncolytic Virus, V937, to Describe Viral Kinetic and Dynamic Processes Following Intratumoral and Intravenous Administration

  2021cites this paper
• Enhancing Oncolytic Virotherapy: Observations from a Voronoi Cell-Based Model.

  2020cites this paper
• The future of cancer treatments: a critical review of mathematical models for combination cancer therapy

  2020cites this paper
• The role of viral infectivity in oncolytic virotherapy outcomes: A mathematical study.

  2020cites this paper
• Application of control theory in a delayed-infection and immune-evading oncolytic virotherapy.

  2020cites this paper
• Drug delivery in tumors is enhanced by bacterial proteolytic activity in a size, pharmacokinetic, and binding affinity dependent manner - A mechanistic understanding.

  2020cites this paper
• Numerical modeling of high-intensity focused ultrasound-mediated intraperitoneal delivery of thermosensitive liposomal doxorubicin for cancer chemotherapy

  2019cites this paper
• Synergistic Effects of Bortezomib-OV Therapy and Anti-Invasive Strategies in Glioblastoma: A Mathematical Model

  2019cites this paper
• In vitro and in silico multidimensional modeling of oncolytic tumor virotherapy dynamics

  2019cites this paper
• Spatial Model for Oncolytic Virotherapy with Lytic Cycle Delay

  2019cites this paper
• Drug delivery in tumors is enhanced by bacterial proteolytic activity in a size and binding affinity dependent manner -A mechanistic understanding

  2019influential citation
• Effects of spatiotemporal HSV-2 lesion dynamics and antiviral treatment on the risk of HIV-1 acquisition

  2018cites this paper
• In Vivo Estimation of Oncolytic Virus Populations within Tumors.

  2018cites this paper
• A New Role for Vitamin D: The Enhancement of Oncolytic Viral Therapy in Pancreatic Cancer

  2018cites this paper
• Stress alleviation strategy in cancer treatment: Insights from a mathematical model

  2018cites this paper
• Research report 2016

  2017cites this paper
• Modeling therapeutic response to radioiodine in metastatic thyroid cancer: a proof-of-concept study for individualized medicine

  2017cites this paper
• Computational modeling approaches to the dynamics of oncolytic viruses

  2016cites this paper
• Spatial stochastic models of HSV-2 lesion dynamics and their link with HIV-1 acquisition

  2016cites this paper
• Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth.

  2016cites this paper
• A mathematical approach to virus therapy of glioblastomas

  2016cites this paper
• The role of the microenvironment in regulation of CSPG-driven invasive and non-invasive tumor growth in glioblastoma

  2015cites this paper
• Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors.

  2015cites this paper
• Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeutics.

  2015cites this paper
• Towards Optimal Design of Cancer Nanomedicines: Multi-stage Nanoparticles for the Treatment of Solid Tumors

  2015cites this paper
• Treatment strategies for combining immunostimulatory oncolytic virus therapeutics with dendritic cell injections.

  2015cites this paper
• Stress-mediated progression of solid tumors: effect of mechanical stress on tissue oxygenation, cancer cell proliferation, and drug delivery

  2015cites this paper
• Mathematical modeling analysis of intratumoral disposition of anticancer agents and drug delivery systems

  2015cites this paper
• The role of the microenvironment in regulation of CSPG-driven invasive and non-invasive tumor growth in glioblastoma

  2015cites this paper
• Novel trends in genetics: transposable elements and their application in medicine.

  2014cites this paper
• Heterogeneous delivery is a barrier to the translational advancement of oncolytic virotherapy for treating solid tumors

  2014cites this paper
• Choindroitinase ABC I-Mediated Enhancement of Oncolytic Virus Spread and Anti Tumor Efficacy: A Mathematical Model

  2014cites this paper
• Introduction to Oncolytic Viruses

  2014cites this paper
• Mathematical models for translational and clinical oncology

  2013cites this paper
• Mathematical Model for Radial Expansion and Conflation of Intratumoral Infectious Centers Predicts Curative Oncolytic Virotherapy Parameters

  2013influential citation
• Computational modeling approaches to studying the dynamics of oncolytic viruses.

  2013cites this paper
• Combining two strategies to improve perfusion and drug delivery in solid tumors

  2013cites this paper
• Mathematical Modeling of Vesicle Drug Delivery Systems 2

  2013cites this paper
• Systemic and biophase bioavailability and pharmacokinetics of nanoparticulate drug delivery systems.

  2013cites this paper
• Combinatorial strategies for oncolytic herpes simplex virus therapy of brain tumors.

  2013cites this paper
• Complex Spatial Dynamics of Oncolytic Viruses In Vitro: Mathematical and Experimental Approaches

  2012cites this paper
• Preclinical Evaluation of a Genetically Engineered Herpes Simplex Virus Expressing Interleukin-12

  2012cites this paper
• Kinetic and Dynamic Computational Model-Based Characterization of New Proteins in Mice: Application to Interferon Alpha Linked to Apolipoprotein A-I

  2012cites this paper
• Dynamics of melanoma tumor therapy with vesicular stomatitis virus: explaining the variability in outcomes using mathematical modeling

  2011cites this paper
• Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies.

  2011cites this paper
• Strategies to Enhance Viral Penetration of Solid Tumors

  2011influential citation
• Lentiviral transfer of an inducible transgene expressing a soluble form of Gas1 causes glioma cell arrest, apoptosis and inhibits tumor growth

  2011cites this paper
• Questing for an optimal, universal viral agent for oncolytic virotherapy.

  2011cites this paper
• Pancreatic Cancer Gene Therapy: From Molecular Targets to Delivery Systems

  2011cites this paper
• A Dynamical Systems Model for Combinatorial Cancer Therapy Enhances Oncolytic Adenovirus Efficacy by MEK-Inhibition

  2011cites this paper
• Predictive models for pressure-driven fluid infusions into brain parenchyma

  2011cites this paper
• Engineering Herpes Simplex Virus for Cancer Oncolytic Virotherapy

  2010cites this paper
• Gene Therapy: A Pharmacokinetic/Pharmacodynamic Modelling Overview

  2010cites this paper
• ONCOLYTIC HERPES SIMPLEX VIRUS 1 (HSV-1) VECTORS: INCREASING TREATMENT EFFICACY AND RANGE THROUGH STRATEGIC VIRUS DESIGN.

  2010cites this paper
• Adenovirus-Derived Vectors for Prostate Cancer Gene Therapy

  2010cites this paper
• Design of virotherapy for effective tumor treatment.

  2010cites this paper
• Delivering nanomedicine to solid tumors

  2010cites this paper
• Frontiers in cancer nanomedicine: directing mass transport through biological barriers.

  2010cites this paper
• "Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironment.

  2009cites this paper